Title : Cangrelor Use Patterns and Transition to Oral P2Y12 Inhibitors Among Patients With Myocardial Infarction: Initial Results From the CAMEO Registry.

Pub. Date : 2022 Jun 7

PMID : 35621210






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Many patients (16.4%) had a >1-hour gap between cangrelor cessation and oral P2Y12 inhibitor initiation; this was highest among those transitioned to clopidogrel (56.6% versus 34.5% prasugrel versus 10.8% ticagrelor; P<0.001). Prasugrel Hydrochloride purinergic receptor P2Y12 Homo sapiens